10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

Vitamin D: The Best "Drug" for Slashing Your Risk of Cancer?

Vitamin D: The Best "Drug" for Slashing Your Risk of Cancer?

Story at-a-glance -

  • Cancer prevention strategies that need to become mainstream include: optimizing your vitamin D levels, normalizing your insulin levels, and exercise. Research shows you can likely cut your cancer-risk in half simply by optimizing your vitamin D levels with sun exposure. And if you are being treated for cancer it is likely that higher blood levels—probably around 70-100 ng/ml—would be beneficial.
  • Cancer rates are projected to rise by 45 percent in the UK over the next 20 years due to population growth and an aging population.
  • Global cost of cancer is estimated at $286 billion annually in medical expenses and lost productivity. According to a new report from a panel of 37 experts, the rate of increase in expenditure on cancer within health-care systems is unsustainable.
  • Ignoring the fact that cancer is likely a man-made disease caused primarily by toxic overload is at the heart of our rising cancer rates, yet most of the cancer research is directed towards expensive drugs that target late stages of the disease and greatly enrich the drug companies but simply do not prevent cancer.
  • Overlooked contributing factors to cancer include: chemical exposures, pharmaceutical drugs, processed and artificial foods, EMF and dirty electricity, radiation exposure, obesity, stress, poor sleeping habits, and lack of sunshine exposure.

By Dr. Mercola

Research in the UK suggests that the number of new cancer cases could rise 45 percent by 2030. 


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access